Biogen Inc.BIIBNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank36
5Y CAGR-21.6%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
-21.6%/yr
Long-term compound
Percentile
P36
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 1.97% |
| 2024 | -4.62% |
| 2023 | 3.87% |
| 2022 | -10.12% |
| 2021 | 6.53% |
| 2020 | 6.65% |
| 2019 | 11.84% |
| 2018 | 8.92% |
| 2017 | -0.69% |
| 2016 | -7.72% |